Concepedia

Tissue and serum EGFR as prognostic factors in malignant pleural mesothelioma

Rabab Gaafar, Abeer A. Bahnassy, Ibrahim M. Abdelsalam, Mahmoud M. Kamel, Amani M. Helal, Amany Abdel-Hamid, Nelly Aly Eldin, Nadia Mokhtar

Lung Cancer · 2010 · 29 citations · 21 references

DOI

Concepts

References

21

A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor.

Fortunato Ciardiello, Giampaolo Tortora · PubMed · 2001 · 988 citations

, , +17

The European mesothelioma epidemic

Julian Peto, Adriano Decarli, Carlo La Vecchia et al. · British Journal of Cancer · 1999 · 900 citations · Full text

, , +17

Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems

John Edwards · PubMed Central · 2000 · 318 citations · Full text

, , +11

Gefitinib in Patients with Malignant Mesothelioma: A Phase II Study by the Cancer and Leukemia Group B

Ramaswamy Govindan, Robert A. Kratzke, James E. Herndon et al. · Clinical Cancer Research · 2005 · 259 citations

, , +14

Phase II Study of Erlotinib in Patients With Malignant Pleural Mesothelioma: A Southwest Oncology Group Study

Linda L. Garland, Cathryn Rankin, David R. Gandara et al. · Journal of Clinical Oncology · 2007 · 222 citations · Full text

, , +17